ARVN-71228

N/A

Report date: 2023/03/02 17:20:30

NME

Base Information

Drug NameARVN-71228

Drug Alias NameARVN-71228

ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)

Mechanisms of ActionB-cell lymphoma 6 protein degraders

TargetsB-cell lymphoma 6 protein

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesArvinas Inc

China Registration ClassN/A

Active CompaniesArvinas Inc

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

ATC CodeN/A